國內罕見疾病研究

台灣最近三年之神經罕見疾病研究

  1. 陳儀莊博士(個人簡介)及中研院生物醫學科學研究所團隊:Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease, Aug 02, 2019. Read more
  2. 陳俊安博士(個人簡介)及中研院分子生物研究所團隊:Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration, May 30, 2019. Read more
  3. 宋秉文醫師(個人簡介)等人:Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology., Ching-Yu Chuang, Chih-Chao Yang, Bing-Wen Soong, Chun-Ying Yu, Shu-Hwa Chen, Hsiang-Po Huang & Hung-Chih Kuo., Scientific Reports. volume 9, Article number:1166 , 2019. Read more
  4. 林恭平醫師(個人簡介): an RNAi Therapeutic for Hereditary Transthyretin Amyloidosis, published in NEJM 2018;379:11 Read more
  5. 陳儀莊教授(個人簡介 ) : Degeneration of ipRGCs in mouse models of HD disrupts non-image forming behaviors prior to motor impairment, published in J Neurosci 2019;39:1505 Read more
  6. 趙啟超/謝松蒼醫師(個人簡介): Skin Nerve Pathology: Biomarkers of Premanifest and Manifest Amyloid Neuropathy., published in Ann Neurol. 8 Feb, 2019. doi: 10.1002/ana.25433 Read more